Xilio Development
Price & Volume
Stats
See more52W Range | $0.50-$1.63 |
Market Cap | $49.3M |
Shares Short | 384,094 |
Financials
See moreRevenue (12 Mos) | $4.6M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $4.6M |
Diluted EPS | -$1.55 |
News
See moreYahoo Finance • 8 hours ago
Xilio Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • last year
Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
About
CEO | Dr. Rene Russo BCPS, Pharm.D. |
Address | 828 Winter Street, Waltham, MA, United States, 02451 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 73 |
